Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Code:
NCT07122219
Conditions
HIV
Hepatitis C Virus (HCV)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NIATx
Brief summary:
Conditions
HIV
Hepatitis C Virus (HCV)
Study ID
NCT07122219
Start date
Oct 1, 2024
Status verified date
Dec, 2025
Completion date
Sep 30, 2029
Anticipated
Primary completion date
Feb 29, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
548 participants
Anticipated
Allocation
Non randomized
Intervention Model
Sequential
Primary purpose
Health Services Research
Arms
experimental: NIATx group 1
experimental: NIATx group 2
experimental: NIATx group 3
Interventions
NIATx
Primary outcome measure
Central contacts
Locations
Dorchester Medium
Recruiting
Dorchester, New Brunswick, Canada, E4K 2Y9
Atlantic Institution
Recruiting
Smiths Crossing, New Brunswick, Canada, E9B 1T9
Nova Institution for Women
Recruiting
Truro, Nova Scotia, Canada, B2N 6R8
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Last update posted
Dec 29, 2025
Last verified
Dec, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre on 2025-12-29.